{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:27:56Z","timestamp":1775021276148,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.atherosclerosis.2015.06.025","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T04:52:20Z","timestamp":1434689540000},"page":"692-700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Hepcidin-ferroportin axis controls toll-like receptor 4 dependent macrophage inflammatory responses in human atherosclerotic plaques"],"prefix":"10.1016","volume":"241","author":[{"given":"Anwer","family":"Habib","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2320-6103","authenticated-orcid":false,"given":"Rohini","family":"Polavarapu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinit","family":"Karmali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Van Dam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokuni","family":"Akahori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Pachura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles C.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6034-5738","authenticated-orcid":false,"given":"Eric","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6007-2044","authenticated-orcid":false,"given":"Frank","family":"Kolodgie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renu","family":"Virmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aloke V.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2015.06.025_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2013an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.06.025_bib2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/90609","article-title":"Toll-like receptors: critical proteins linking innate and acquired immunity","volume":"2","author":"Akira","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.06.025_bib3","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1161\/CIRCRESAHA.106.142851","article-title":"Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity","volume":"100","author":"Kim","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2015.06.025_bib4","doi-asserted-by":"crossref","first-page":"10679","DOI":"10.1073\/pnas.0403249101","article-title":"Lack of toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein e","volume":"101","author":"Michelsen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2015.06.025_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s00125-008-1221-7","article-title":"Impact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice","volume":"52","author":"Coenen","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2015.06.025_bib6","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.2337\/db11-1595","article-title":"Toll-like receptor 4 deficiency promotes the alternative activation of adipose tissue macrophages","volume":"61","author":"Orr","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2015.06.025_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJMoa012673","article-title":"Toll-like receptor 4 polymorphisms and atherogenesis","volume":"347","author":"Kiechl","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.06.025_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ni.1836","article-title":"Cd36 ligands promote sterile inflammation through assembly of a toll-like receptor 4 and 6 heterodimer","volume":"11","author":"Stewart","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.06.025_bib9","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1161\/01.ATV.0000143933.20616.1b","article-title":"Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein e knockout mice","volume":"24","author":"Branen","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.06.025_bib10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cmet.2010.06.008","article-title":"Myeloid type i interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions","volume":"12","author":"Goossens","year":"2010","journal-title":"Cell. Metab."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.06.025_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jacc.2011.10.852","article-title":"Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques","volume":"59","author":"Finn","year":"2012","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.06.025_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacc.2009.09.007","article-title":"Relationship of thrombus healing to underlying plaque morphology in sudden coronary death","volume":"55","author":"Kramer","year":"2010","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.06.025_bib13","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/01.ATV.20.5.1262","article-title":"Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions","volume":"20","author":"Virmani","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.06.025_bib14","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/nm.1888","article-title":"Bmp type i receptor inhibition reduces heterotopic [corrected] ossification","volume":"14","author":"Yu","year":"2008","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.06.025_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1161\/ATVBAHA.111.240101","article-title":"Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis","volume":"32","author":"Saeed","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.06.025_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cmet.2005.01.003","article-title":"The iron exporter ferroportin\/slc40a1 is essential for iron homeostasis","volume":"1","author":"Donovan","year":"2005","journal-title":"Cell. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.06.025_bib17","first-page":"3322","article-title":"Selective modulation of tlr4-activated inflammatory responses by altered iron homeostasis in mice","volume":"119","author":"Wang","year":"2009","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.atherosclerosis.2015.06.025_bib18","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2015.06.025_bib19","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1172\/JCI42011","article-title":"Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice","volume":"120","author":"De Domenico","year":"2010","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.atherosclerosis.2015.06.025_bib20","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1084\/jem.20060845","article-title":"Carbon monoxide differentially inhibits tlr signaling pathways by regulating ros-induced trafficking of tlrs to lipid rafts","volume":"203","author":"Nakahira","year":"2006","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.atherosclerosis.2015.06.025_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev.cellbio.14.1.111","article-title":"Functions of lipid rafts in biological membranes","volume":"14","author":"Brown","year":"1998","journal-title":"Annu Rev. Cell. Dev. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.06.025_bib22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/88765","article-title":"Antigen-induced translocation of pkc-theta to membrane rafts is required for t cell activation","volume":"2","author":"Bi","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.06.025_bib23","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood-2005-04-1766","article-title":"Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs","volume":"106","author":"Rivera","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2015.06.025_bib24","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1111\/j.1582-4934.2010.01121.x","article-title":"Macrophages heterogeneity in atherosclerosis - implications for therapy","volume":"14","author":"Wilson","year":"2010","journal-title":"J.\u00a0Cell. Mol. Med."},{"key":"10.1016\/j.atherosclerosis.2015.06.025_bib25","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1369\/jhc.5A6871.2006","article-title":"Am-3k, an anti-macrophage antibody, recognizes cd163, a molecule associated with an anti-inflammatory macrophage phenotype","volume":"54","author":"Komohara","year":"2006","journal-title":"J.\u00a0Histochem Cytochem"},{"key":"10.1016\/j.atherosclerosis.2015.06.025_bib26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.coph.2006.01.010","article-title":"Understanding and exploiting the endogenous interleukin-10\/stat3-mediated anti-inflammatory response","volume":"6","author":"Murray","year":"2006","journal-title":"Curr. Opin. Pharmacol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015013799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015013799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T12:57:30Z","timestamp":1537534650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915015013799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0021915015013799"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.06.025","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepcidin-ferroportin axis controls toll-like receptor 4 dependent macrophage inflammatory responses in human atherosclerotic plaques","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}